ATC Group: B03XA08 Vadadustat

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B03XA08 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B03 Antianemic preparations
3 B03X Other antianemic preparations
4 B03XA Other antianemic preparations
5 B03XA08

Active ingredients in B03XA08

Active Ingredient Description
Vadadustat

Vadadustat is a hypoxia-inducible factor prolyl-hydroxylase inhibitor which leads to increased cellular levels of hypoxia-inducible factor thereby stimulating endogenous erythropoietin (EPO) production, increasing iron mobilization and red blood cell production, resulting in gradual rate of rise in Hb.

Related product monographs

Title Information Source Document Type  
VAFSEO Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

Estonia (EE)

Ireland (IE)

Italy (IT)

Japan (JP)

Lithuania (LT)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.